Prevention of Contraceptive Failures with Hormonal Implants

  • Anibal Faundes


Hormonal implants have been in the process of research and development for the last 17 years. Up to the present time the only model which has become a finished product is the NORPLANT(R)* implant system, manufactured by Leiras Pharmaceuticals from Finland under license from the Population Council of New York. A few other models, such as CAPRONOR(R) and a second NORPLANT implant system, are well advanced in the development process.


Family Planning Unwanted Pregnancy Cervical Mucus Contraceptive Failure Population Council 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alvarez, F., Brache, V., Faundes, A., et al. Levonorgestrel plasma level during continuous administration with different models of subdermal implants. Contraception 27(2):123, 1983.PubMedCrossRefGoogle Scholar
  2. Bonnar, J., McNicol, G. P., Douglas, A. S. Blood coagulation and fibrinolysis. In Ronald R. Macdonald, ed., Scientific Basis of Obstetrics and Gynaecology. J & A Churchill, London, p. 207, 1971.Google Scholar
  3. Brache, V., Faundes, A., Johansson, E., et al. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of NORPLANT(R) implants. Contraception 31(3):261, 1985.PubMedCrossRefGoogle Scholar
  4. Croxatto, H. B., Diaz, S., Miranda, P., Pavez, M. Plasma levels of levonorgestrel in women during long-term use of NORPLANT(R). Contraception 23(2):197, 1981.PubMedCrossRefGoogle Scholar
  5. Croxatto, H. B., Diaz, S., Robertson, D. N., et al. Clinical chemistry in women treated with levonorgestrel implants. Contraception 27(3):281, 1983.PubMedCrossRefGoogle Scholar
  6. Faundes, A., Sivin, I., Stern, J. Long-acting contraceptive implants; an analysis of menstrual bleeding patterns. Contraception 18(4):355, 1978.PubMedCrossRefGoogle Scholar
  7. Hardy, E., Herud, K. Effectiveness of a contraceptive education program for post-abortion patients in Chile. Studies in Family Planning 6(7):188, 1975.PubMedCrossRefGoogle Scholar
  8. Lubis, F., Prihartono, J., Agoestina, T., et al. One year experience of NORPLANT(R) implants in Indonesia. Studies in Family Planning 14(6–7):181, 1983.PubMedCrossRefGoogle Scholar
  9. Marangoni, P., Cartagena, S., Alvarado, J., et al. NORPLANT(R) implants and the TCu 200 IUD: A comparative study in Ecuador. Studies in Family Planning 14(6–7):177, 1983.PubMedCrossRefGoogle Scholar
  10. Nilsson, C. G., Holma, P. Menstrual blood loss with contraceptive subdermal levonorgestrel implants. Fertility and Sterility 35(3):304, 1981.PubMedGoogle Scholar
  11. Requena, M. The problem of induced abortion in Latin America. Demography (2):785, 1968.Google Scholar
  12. Satayapan, S., Kanchanasinith, K., Varakamin, S. Perception and acceptability of NORPLANT(R) implants in Thailand. Studies in Family Planning 14(6–7): 170, 1983.PubMedCrossRefGoogle Scholar
  13. Shaaban, M. M., Salah, M., Zarzour, A., Abdullah, A. A prospective study of NORPLANT(R) implants and the T-Cu 380 Ag IUD in Assiut, Egypt. Studies in Family Planning 14(6–7):163, 1983.PubMedCrossRefGoogle Scholar
  14. Shaaban, M. M., Elwan, S. I., El-Sharkawy, M. M., Farghaly, A. S. Effect of subdermal levonorgestrel contraceptive implants, NORPLANT(R), on liver functions. Contraception 30(5):407, 1984a.PubMedCrossRefGoogle Scholar
  15. Shaaban, M. M., Elwan, S. I., Abdalla, S. A., Darwish, H. A. Effect of subdermal levonorgestrel contraceptive implants, NORPLANT(R), on serum lipids. Contraception 30(5):413, 1984b.PubMedCrossRefGoogle Scholar
  16. Shaaban, M. M., Elwan, S. I., El-Kabsh, M. Y., et. al. Effect of levonorgestrel contraceptive implants, NORPLANT(R), on blood coagulation. Contraception 30(5):421, 1984c.PubMedCrossRefGoogle Scholar
  17. Sivin, I., Diaz, S., Holma, P., et al. A four-year clinical study of NORPLANT(R) implants. Studies in Family Planning 14(6–7):184, 1983.PubMedCrossRefGoogle Scholar
  18. The International Committee for Contraception Research of The Population Council. Contraception with long-acting subdermal implants: I. An effective and acceptable modality in international clinical trials. Contraception 18(4):315, 1978.Google Scholar
  19. Weiner, E., Victor, A., Johansson, E. D. B. Plasma levels of d-norgestrel after oral administration. Contraception 14(5):563, 1976.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Anibal Faundes
    • 1
  1. 1.Universidade Estadual de CampinasCampinasBrazil

Personalised recommendations